SOLIGENIX
Soligenix is a late-stage research and development biopharmaceutical company that focuses on developing products to treat the life-threatening side effects of cancer treatment and serious gastrointestinal diseases where there remains an unmet medical need, as well as developing biodefense vaccines and therapeutics. The company maintains two business segments: BioTherapeutics and BioDefense. Its BioTherapeutics business segment focuses to develop oral beclomethasone dipropionate (orBec or oral BDP) and other biotherapeutic products, including LPMTM Leuprolide. Its BioDefense business segment focuses to convert its ricin toxin vaccine and radiation injury program from early-stage development to advanced development and manufacturing.
SOLIGENIX
Industry:
Biopharma Biotechnology Health Care Medical
Founded:
1987-01-01
Address:
Princeton, New Jersey, United States
Country:
United States
Website Url:
http://www.soligenix.com
Total Employee:
11+
Status:
Active
Contact:
+1 609-538-8200
Email Addresses:
[email protected]
Total Funding:
43.53 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins
Similar Organizations
Sagimet Biosciences
Sagimet Biosciences is a biotechnology company that focuses on developing novel therapeutics to treat important diseases.
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
Aerial BioPharma
Aerial BioPharma is a biopharmaceutical company developing biologics and small molecules for central nervous system issues.
ANTERIOS
Anterios is a biopharmaceutical company developing botulinum-based prescription products for aesthetic medicine and dermatology.
Apexigen
Apexigen is a clinical-stage biopharmaceutical company focused on discovering and developing a new antibody therapeutics for oncology.
Arno Therapeutics
Arno Therapeutics is a biopharmaceutical company developing innovative products for the treatment of cancer patients.
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Avalyn Pharma
Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.
BioNTech
BioNTech is a biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Chiasma
Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.
D2G Oncology
D2G Oncology is a biotechnology company that specializes in relating drugs to genotypes to transform precision cancer therapeutics.
DermBiont
DermBiont is a biotech company that develops skin microbiome therapeutics to treat and prevent skin diseases.
Dynavax Technologies
Dynavax Technologies is a biopharmaceutical company discovering and developing novel products to prevent and treat infectious diseases.
Eiger BioPharmaceuticals
Eiger is a biopharmaceutical company that develops new antiviral agents against novel targets in the treatment of hepatitis.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
Epizyme
Epizyme is a biopharmaceutical company focusing on treatments for blood cancer and tumors.
Fedora Pharmaceuticals
Fedora Pharmaceuticals engages in the discovery and development of antibiotics for life-threatening microbial drug resistance needs.
Flexus Biosciences
Flexus is a privately-held biopharmaceutical company focused on the creation of novel anti-cancer therapeutics.
Genelux
Genelux, a clinical-stage biopharmaceutical company, develops diagnostic and therapeutic solutions for cancer and inflammatory diseases.
Vero Biotech
Vero Biotech is a biopharmaceutical company that commercializes inhaled nitric oxide delivery systems for healthcare providers.
Genocea Biosciences
Genocea Biosciences is a biopharmaceutical company which is engaged in developing novel vaccines and immunotherapies.
Healx
Healx is an AI-powered, patient-inspired technology company, pioneering the next generation of drug discovery for rare diseases.
HebeCell
HebeCell develops and commercializes cell-based therapeutics to treat incurable diseases.
Kinnate Biopharma
Kinnate Biopharma develops precision oncology therapeutics to treat patients with genomically-defined cancers.
Kite Pharma
Kite Pharma is a development-stage biotechnology company designing and developing immune-based therapies to treat cancer indications..
Kura Oncology
Kura Oncology, a biopharmaceutical company, advances a pipeline of precision medicines for the treatment of solid tumors and blood cancers.
Marinomed
Marinomed is a biopharmaceutical company that develops innovative anti-viral and immunological treatments.
Mast Therapeutics
Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.
Moerae Matrix
Moerae Matrix is a biopharmaceutical company developing targeted therapeutics for fibrotic diseases.
Neurolixis
Neurolixis is a biopharmaceutical company that develops drugs for the treatment of central nervous system disorders.
Otonomy
Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
Penn Medicine
Penn Medicine is the medical school of the University of Pennsylvania that provides medical research and education services.
Raptor Pharmaceuticals
Raptor is a NASDAQ-listed biopharmaceutical company with the mission to develop and commercialize life-altering therapeutics.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
RegeneRx
RegeneRx is a biopharmaceutical company that designs, researches, and develops novel peptides targeted at diseases with unmet medical needs.
Relypsa
Relypsa is a biopharmaceutical company developing drugs for treating cardiovascular and renal diseases.
Sojournix
Sojournix is a biotechnology company developing innovative medicines for women's health and endocrine disorders.
Sorrento Therapeutics
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
CHF Solutions
CHF Solutions is a medical device company that focuses on innovative cardiac assist therapy to treat patients.
TissueGene
TissueGene is a biopharmaceutical company focused on developing regenerative therapies for the treatment of various orthopedic disorders.
Urovant Sciences
Urovant Sciences is a global biopharmaceutical company focused on developing novel therapies for urologic conditions.
Y-mAbs Therapeutics
YmAbs is a clinical stage biopharmaceutical company that discovers and develops innovative treatments for cancer patients.
Current Advisors List
Current Employees Featured
Stock Details
Investors List
U.S. Food and Drug Administration
U.S. Food and Drug Administration investment in Grant - Soligenix
Cabinet Office - GOV.UK
Cabinet Office - GOV.UK investment in Grant - Soligenix
New Jersey Economic Development Authority
New Jersey Economic Development Authority investment in Grant - Soligenix
New Jersey Economic Development Authority
New Jersey Economic Development Authority investment in Grant - Soligenix
National Institutes of Health
National Institutes of Health investment in Grant - Soligenix
New Jersey Economic Development Authority
New Jersey Economic Development Authority investment in Grant - Soligenix
National Institutes of Health
National Institutes of Health investment in Grant - Soligenix
Biomedical Advanced Research and Development Authority (BARDA)
Biomedical Advanced Research and Development Authority (BARDA) investment in Grant - Soligenix
National Institute of Allergy and Infectious Diseases
National Institute of Allergy and Infectious Diseases investment in Grant - Soligenix
Kodiak Capital Group
Kodiak Capital Group investment in Venture Round - Soligenix
Official Site Inspections
http://www.soligenix.com Semrush global rank: 1.89 M Semrush visits lastest month: 11.64 K
- Host name: 42.57.196.35.bc.googleusercontent.com
- IP address: 35.196.57.42
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Soligenix"
About Soligenix, a late-stage biopharmaceutical company
Soligenix is developing HyBryteâ„¢ as a first-in-class photo-dynamic therapy utilizing safe visible light for the treatment of cutaneous T-cell lymphoma, SGX942, a novel innate defense …See details»
Meet Our Executive Team - Soligenix
Prior to joining Soligenix, Dr. Schaber served from 1998 to 2006 as Executive Vice President and Chief Operating Officer of Discovery Laboratories, Inc., where he was responsible for overall pipeline development and key areas of …See details»
Soligenix - Crunchbase Company Profile & Funding
Soligenix is a late-stage research and development biopharmaceutical company that focuses on developing products to treat the life-threatening side effects of cancer treatment and serious gastrointestinal diseases where there remains …See details»
Soligenix, Inc. - LinkedIn
Soligenix, Inc. | 5,861 followers on LinkedIn. We are a late-stage biopharmaceutical company focused on developing & commercializing products to treat rare diseases | Soligenix is a late-stage ...See details»
Soligenix Investor Relations - Investor Relations
Nov 19, 2024 Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet...See details»
Soligenix, Inc. (SNGX) Company Profile & Overview - Stock Analysis
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. The company operates …See details»
Soligenix - Funding, Financials, Valuation & Investors - Crunchbase
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases. Search Crunchbase. Start Free Trial . ... How much funding has this …See details»
Soligenix Company Profile - Office Locations, Competitors, …
Oct 29, 2024 Soligenix has 4 employees at their 1 location and $839.36 k in annual revenue in FY 2023. See insights on Soligenix including office locations, competitors, revenue, financials, …See details»
Soligenix Corporate Update Letter - Key Highlights and Upcoming ...
PRINCETON, N.J., Jan. 10, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and …See details»
News Releases - Soligenix Investor Relations
PRINCETON, N.J., Oct. 12, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and …See details»
Meet Our Board of Directors - Soligenix
The Soligenix Board of Directors is made up of persons with many years experience in the healthcare, pharma, and biosciences fields. ... and has been a member of the corporate …See details»
Soligenix Announces Recent Accomplishments And Third Quarter …
PRINCETON, N.J., Nov. 10, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and …See details»
Rare Disease Pipeline and Programs - Soligenix
Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need.. Soligenix has …See details»
Soligenix Corporate Update Letter - PR Newswire
PRINCETON, N.J., Jan. 10, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and …See details»
Soligenix Investor Relations - News Releases
Oct 16, 2024 Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare …See details»
FDA Grants Soligenix Orphan Drug Designation for the Treatment …
PRINCETON, N.J., Sept. 9, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and …See details»
Our Focus on Unmet Medical Needs - Soligenix
In the biodefense context, ricin toxin is a Category B biothreat and Soligenix is using its proprietary thermal stabilization technology, ThermoVax ®, to advance its world-leading ricin …See details»
Soligenix Announces Accelerated Publication Demonstrating …
PRINCETON, N.J., Sept. 28, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and …See details»
Our Expertise in Clinical Trials - Soligenix
Soligenix will begin recruiting patients into this Phase 2 study with sites in the US. Phase 2a Study Evaluating SGX302 in the Treatment of Mild-to-Moderate Psoriasis This study is to evaluate …See details»